Evolve BioSystems is an infant microbiome company dedicated to developing the next generation of products to establish, restore and maintain a healthy gut microbiome. The foundation is working with Evolve to further develop and apply its lead probiotic, Evivo, to Read More
June 12, 2018 DAVIS, Calif., June 13, 2018 /PRNewswire/ — Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & Melinda Gates Foundation, Read More
By Latika Bourke July 22, 2018 London: An Australian company has won unprecedented US approval for a new drug to treat the second most common preventable cause of blindness in the world. In the process, Medicines Development for Global Health, Read More
By Conor Hale May 9, 2018 Genentech signed a broad, open-ended drug discovery collaboration with Lodo Therapeutics that could be worth nearly $1 billion, focused on deriving unique, natural products from the microbial DNA found in soil. The drugmaker plans Read More
April 26, 2018 SOUTH SAN FRANCISCO, Calif., April 26, 2018 (GLOBE NEWSWIRE) — Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced that it has entered into an award agreement with Read More
By Rebecca Ratcliffe April 16, 2018 David* is perched on a stool, staring at the table in front of him. On it, a small testing stick stands in a cylinder of liquid. “I’ve never tested before, so I thought I Read More
By Matthew Herper January 8, 2018 Bill Gates addressed top executives at the annual J.P. Morgan Health Care Conference in San Francisco. This address was part of the foundation’s efforts to encourage the private sector to invest in global health. Read More
By Ivan Levingston January 8, 2018 The Bill & Melinda Gates Foundation is growing private sector partnerships and encouraging biotech professionals to invest in public health. The foundation’s Program Related Investments Team is highlighted as a business case to demonstrate Read More
Zyomyx is a private biotechnology company specializing in HIV CD4 diagnostics.
Visterra is a biotechnology company that uses its proprietary platform to identify unique disease targets and design and engineer effective biological therapeutics.